Publish Time: 2023-12-14 Origin: Site
2023-12-14
On 13th December, Japan‘s Ministry of Health, Labor and Welfare has confirmed that a man from Saitama Prefecture, who is in his 30s, has died with Monkeypox. This is the first confirmed death case of Mpox in Japan.[1] He was confirmed to be infected with Mpox in September this year, and died last month. He is also said to be infected with human immunodeficiency virus (HIV), therefore he was immunocompromised.
The World Health Organization (WHO) announced the rename Monkeypox to Mpox in November 2022, aiming for a more neutral and accurate term, for the purpose of anti stigma and discrimination.[2]
Mpox usually causes symptoms such as fever and rash, for most cases, the symptoms are mild and self-limiting. While for young children, pregnant women, and immunocompromised people, it can develop severe symptoms. The fatality rate of Mpox is said to be about 0%, but there have been cases of severe illness and death in people infected with HIV or immunodeficient due to other diseases. If you are at high risk of becoming seriously ill and you suspect that you may be infected with Mpox and your condition worsens, please do not hesitate to visit a medical institution and undergo tests and treatment as soon as possible.[3]
Early and accurate diagnosis is crucial for managing Mpox infections and optimizing patient outcomes. Goldsite offers point-of-care (POC) rapid Mpox antigen/antibody test kits, enabling healthcare professionals to instantly diagnose suspected cases. This swift diagnosis empowers timely intervention and improves patient prognosis.
GOLDSITE DIGANOSTICS INC. is a leading manufacturer of IVD products dedicated to the healthcare sector. With over 24 years of expertise in the IVD industry, Goldsite has established itself as a trusted partner since 1999. With a team of experts in the field of diagnostics technology and a passion for improving healthcare, we strive to bring cutting-edge products to market that meet the evolving needs of health providers and patients. Engaged in R&D, manufacturing, and marketing of clinical laboratory devices and reagents, Goldsite has a portfolio of products covering specific proteins, chemistry, chemiluminescence, and POCT platform, as well as associated reagents. All products live up to global standards with CE marking and have been exported to more than 80+ countries.
Our vision is to deliver state-of-art solutions that enhance patient care and improve health outcomes. We are dedicated to providing healthcare professionals with the tools they need to deliver accurate and reliable diagnoses, while also making medical diagnostics more accessible and affordable for all. We aim to make a positive impact on global health and well-being.
For more information, stay connected with us on our social media platforms to keep up-to-date with the latest industry news and trends, as well as insights and updates from our company. Follow us on Facebook, LinkedIn, YouTube, Twitter to be the first to know about our new products and services, events, and exciting R&D updates.
Link to our social media platform:
| | | | | |
| X(Twitter) | YouTube | TikTok |
Home Products About Goldsite Support Solutions Download News Contact Us Privacy Policy